Study of Biological Effects by Pulsed Bremsstrahlung Radiation of Ultrahigh Dose Rate at the Angara-5-1 Facility
- Authors: Smirnov V.P.1, Bozhenko V.K.2, Gimadova T.I.3, Grabovski E.V.4, Gritsuk A.N.4, Ivanov A.V.2, Oleinik G.M.4, Khmelevskii E.V.5, Tsov’yanov A.G.3, Shishkin A.M.2
-
Affiliations:
- Joint Institute for High Temperatures, Russian Academy of Sciences
- Russian Scientific Center of Roentgenoradiology
- State Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency
- Troitsk Institute for Innovation and Fusion Research
- Hertsen Moscow Oncology Research Center, Branch of FSBI NMRRC of the Ministry of Health of Russia
- Issue: Vol 44, No 12 (2018)
- Pages: 1169-1174
- Section: Brief Communications
- URL: https://journals.rcsi.science/1063-780X/article/view/187025
- DOI: https://doi.org/10.1134/S1063780X18120103
- ID: 187025
Cite item
Abstract
Radiological methods of treatment of malignant tumors are widespread in medical practice. In addition to the type of radiation and dose and fractionation of the radiation regime, the dose rate is one of the factors that affects the effectiveness of treatment. The therapeutic dose rate lies in the range of tens of mGy/s. At modern high-current accelerators of relativistic electron beams, a significant increase in the dose rate to hundreds of MGy/s is achievable, which is more than 108 times greater than the therapeutic dose rate. It is difficult to predict the nature of processes in tissues and its cells at such radiation intensities. To determine the effect of extreme dose rate on the radiosensitivity of tissues at the Angara-5-1 facility, experiments were conducted to determine the lethal dose (LD50/30) for laboratory mice. Our result on the study of the LD50/30 dose (~100 MGy/s) allows us to make a conclusion about a possible higher lethal dose than the power range of the doses used for medical purposes.
About the authors
V. P. Smirnov
Joint Institute for High Temperatures, Russian Academy of Sciences
Email: oleinik@triniti.ru
Russian Federation, Moscow, 125412
V. K. Bozhenko
Russian Scientific Center of Roentgenoradiology
Email: oleinik@triniti.ru
Russian Federation, Moscow, 117997
T. I. Gimadova
State Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency
Email: oleinik@triniti.ru
Russian Federation, Moscow, 123098
E. V. Grabovski
Troitsk Institute for Innovation and Fusion Research
Email: oleinik@triniti.ru
Russian Federation, Moscow, 142190
A. N. Gritsuk
Troitsk Institute for Innovation and Fusion Research
Email: oleinik@triniti.ru
Russian Federation, Moscow, 142190
A. V. Ivanov
Russian Scientific Center of Roentgenoradiology
Email: oleinik@triniti.ru
Russian Federation, Moscow, 117997
G. M. Oleinik
Troitsk Institute for Innovation and Fusion Research
Author for correspondence.
Email: oleinik@triniti.ru
Russian Federation, Moscow, 142190
E. V. Khmelevskii
Hertsen Moscow Oncology Research Center, Branch of FSBI NMRRC of the Ministry of Health of Russia
Email: oleinik@triniti.ru
Russian Federation, Moscow, 125284
A. G. Tsov’yanov
State Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency
Email: oleinik@triniti.ru
Russian Federation, Moscow, 123098
A. M. Shishkin
Russian Scientific Center of Roentgenoradiology
Email: oleinik@triniti.ru
Russian Federation, Moscow, 117997
Supplementary files
